Oliveto Joseph 4
4 · Milestone Pharmaceuticals Inc. · Filed Jun 8, 2020
Insider Transaction Report
Form 4
Oliveto Joseph
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Shares
2019-12-21$1.54/sh+7,400$11,396→ 280,555 total - Award
Employee Stock Option (right to buy)
2020-06-05+150,000→ 150,000 totalExercise: $3.74Exp: 2030-06-05→ Common Shares (150,000 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2019-12-21−7,400→ 113,856 totalExercise: $1.54Exp: 2027-12-12→ Common Shares (7,400 underlying)
Footnotes (2)
- [F1]The original grant was for 252,853 option shares. Twenty-five percent (25%) of the shares subject to the option vested on September 19, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]The shares subject to this option shall vest in twenty-four (24) equal monthly installments commencing on July 5, 2020, subject to the recipient continuing to provide service to the Issuer through each such date.